TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support wellness in innovative ways, today announced a reorganization of its Board of Directors. As part of Lifeist’s ongoing efforts to enhance corporate governance and further strengthen its leadership structure, Meni Morim, a director of the Company and the former CEO of the Company, ha ...

TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support wellness in innovative ways, is pleased to announce the appointment of Andrea Judge as Chief Executive Officer of Lifeist Wellness Inc. effective today. Andrea, the current CEO of Lifeist's subsidiary Mikra Cellular Sciences Inc. (“Mikra”) since July 2024, will now lead Lifeist in ...

CHICAGO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Zarminali Health, the first outpatient pediatric destination purpose-built to provide modern, seamlessly coordinated primary and specialty care nationwide, today announced $40M in seed financing led by General Catalyst. The company will leverage the latest healthcare technology and an integrated approach to both primary and specialty care that alleviates family burdens and revitalizes patient and clinician experiences. This substantial funding, including a venture ...

LifeStance Health Group, Inc. (NASDAQ:LFST) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants Monica Prokocki - Vice President of Investor Relations Ken Burdick - Chief Executive Officer Dave Bourdon - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Jack Senft - William Blair Jamie Perse - Goldman Sachs Stephanie Davis - Barclays Operator Thank you for standing by. My name is Liz and I'll be your conference operator today. At this time, ...

| --- | --- | |-------------|-------| | | | | | | | | | | | | | Reimagining | | Forward-Looking Statements DISCLAIMERS Cautionary Note Regarding Forward-Looking Statements This presentation and related oral statements, including during any question and answer portion of the presentation, contain forward-looking statements about LifeStance Health Group, Inc. and its subsidiaries ("LifeStance") and the industry in which LifeStance operates, including statements regarding: full-year and fourth quarter guidance ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share LFST The Nasdaq Stock Market LLC FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ...

LifeStance Health Group (LFST) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 71.43%. A quarter ago, it was expected that this outpatient mental health services provider would post a loss of $0.07 per share when it actually produced a loss of $0.06, delivering a surprise of 14.29%.Over the l ...

SCOTTSDALE, Ariz., Nov. 07, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2024. (All results compared to prior-year comparative period, unless otherwise noted)Q3 2024 Highlights and FY 2024 Outlook Revenue of $312.7 million increased 19% compared to revenue of $262.9 millionClinician base increased 13% to 7,269 clinicians, a sequential ne ...

Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Finance & Investor Relations 602-767-2100 investor.relations@lifestance.com LifeStance Reports Third Quarter 2024 Results SCOTTSDALE, Ariz. – November 7, 2024 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2024. (All results compared to prior-year comparative period, unless otherwise noted) Q3 2024 Hi ...

TORONTO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today reported its financial results for the three months ended August 31, 2024 ("Q3 2024") compared to the same period last year ("Q3 2023"). All financial figures are in Canadian dollars unless otherwise indicated. Third Quarter ...